RENTON HOLLINGS
Insider CIK 1187333 · RIGL Director · CPHD Director · AFFY Director · PTLA Director · ANAB Director · ZYME Director · KYTH Director · ZYME Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2026-10-01 | 2026-10-02 | 5,000 | — | $0 | 10,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2026-10-01 | 2026-10-02 | 5,000 | $49.87 | $249.4K | 10,995 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2026-10-01 | 2026-10-02 | 5,000 | $18.03 | $90.2K | 15,995 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2026-06-15 | 2026-06-17 | 6,030 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2026-06-15 | 2026-06-17 | 6,030 | — | $0 | 10,995 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 10,600 | — | $0 | 10,600 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 10,600 | — | $0 | 10,600 | SEC↗ |
| ANAB ANAPTYSBIO, INC | D To issuer deriv | 2026-04-20 | 2026-04-22 | 9,200 | — | $0 | 9,200 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-04-20 | 2026-04-22 | 9,200 | — | $0 | 9,200 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-01-06 | 2026-01-08 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2026-01-06 | 2026-01-08 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2025-08-08 | 2025-08-12 | 10,231 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2025-08-08 | 2025-08-12 | 10,231 | $6.93 | $70.9K | 15,196 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2025-08-08 | 2025-08-12 | 7,121 | $19.70 | $140.3K | 4,965 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2025-08-08 | 2025-08-12 | 3,110 | $19.44 | $60.5K | 12,086 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2025-07-02 | 2025-07-03 | 20,925 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2025-07-02 | 2025-07-03 | 7,250 | $23.09 | $167.4K | 18,640 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2025-07-02 | 2025-07-03 | 13,675 | $23.82 | $325.7K | 4,965 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2025-07-02 | 2025-07-03 | 20,925 | $6.93 | $145.0K | 25,890 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2025-06-18 | 2025-06-20 | 3,015 | $23.97 | $72.3K | 4,965 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2025-06-15 | 2025-06-17 | 6,030 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2025-06-15 | 2025-06-17 | 6,030 | — | $0 | 7,980 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2025-01-07 | 2025-01-07 | 6,030 | — | $0 | 6,030 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2025-01-07 | 2025-01-07 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2024-11-29 | 2024-12-03 | 10,000 | — | $0 | 20,925 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2024-11-29 | 2024-12-03 | 10,000 | $25.00 | $250.0K | 1,950 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2024-11-29 | 2024-12-03 | 10,000 | $6.93 | $69.3K | 11,950 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2024-07-15 | 2024-07-17 | 10,000 | — | $0 | 30,925 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2024-07-15 | 2024-07-17 | 7,103 | $30.50 | $216.6K | 4,847 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2024-07-15 | 2024-07-17 | 2,897 | $30.98 | $89.7K | 1,950 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2024-07-15 | 2024-07-17 | 10,000 | $6.93 | $69.3K | 11,950 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2024-06-18 | 2024-06-18 | 1,950 | $23.16 | $45.2K | 1,950 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise deriv | 2024-06-15 | 2024-06-18 | 3,900 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO, INC | M Exercise | 2024-06-15 | 2024-06-18 | 3,900 | — | $0 | 3,900 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2024-01-03 | 2024-01-05 | 16,510 | — | $0 | 16,510 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2024-01-03 | 2024-01-05 | 6,030 | — | $0 | 6,030 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2023-12-07 | 2023-12-08 | 37,000 | — | $0 | 37,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-01-06 | 2023-01-10 | 10,600 | — | $0 | 10,600 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2023-01-06 | 2023-01-10 | 3,900 | — | $0 | 3,900 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2022-12-21 | 2022-12-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2022-02-10 | 2022-02-14 | 9,200 | — | $0 | 9,200 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2021-05-06 | 2021-05-07 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2021-02-10 | 2021-02-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 11,377 | $0.06 | $683 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer deriv | 2020-07-02 | 2020-07-02 | 59,092 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 2,826 | $18.00 | $50.9K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 13,194 | $18.00 | $237.5K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | D To issuer | 2020-07-02 | 2020-07-02 | 7,281 | $18.00 | $131.1K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2020-06-12 | 2020-06-15 | 11,377 | — | $0 | 11,377 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2020-06-12 | 2020-06-15 | 7,281 | — | $0 | 20,475 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2020-05-08 | 2020-05-12 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ANAB ANAPTYSBIO, INC | A Award deriv | 2020-02-12 | 2020-02-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2019-11-01 | 2019-11-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2019-11-01 | 2019-11-04 | 5,000 | $9.00 | $45.0K | 18,194 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2019-11-01 | 2019-11-04 | 5,000 | $30.00 | $150.0K | 13,194 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2019-08-08 | 2019-08-09 | 5,000 | — | $0 | 10,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2019-08-08 | 2019-08-09 | 5,000 | $9.00 | $45.0K | 18,194 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2019-08-08 | 2019-08-09 | 5,000 | $30.00 | $150.0K | 13,194 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2019-06-13 | 2019-06-17 | 6,991 | — | $0 | 6,991 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2019-06-13 | 2019-06-17 | 4,194 | — | $0 | 13,194 | SEC↗ |
| ZYME Zymeworks Inc. | A Award deriv | 2019-05-06 | 2019-05-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2019-04-15 | 2019-04-16 | 5,000 | — | $0 | 15,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2019-04-15 | 2019-04-16 | 4,600 | $34.40 | $158.2K | 9,400 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2019-04-15 | 2019-04-16 | 400 | $35.07 | $14.0K | 9,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2019-04-15 | 2019-04-16 | 5,000 | $9.00 | $45.0K | 14,000 | SEC↗ |
| ANAB ANAPTYSBIO INC | A Award deriv | 2019-02-08 | 2019-02-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2018-06-08 | 2018-06-08 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2018-06-08 | 2018-06-08 | 3,000 | — | $0 | 9,000 | SEC↗ |
| ANAB ANAPTYSBIO INC | A Award deriv | 2018-02-02 | 2018-02-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2017-06-16 | 2017-06-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2017-06-16 | 2017-06-19 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ANAB ANAPTYSBIO INC | A Award deriv | 2017-02-24 | 2017-02-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CPHD CEPHEID | D To issuer deriv | 2016-11-04 | 2016-11-07 | 16,300 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | D To issuer deriv | 2016-11-04 | 2016-11-07 | 7,800 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | D To issuer deriv | 2016-11-04 | 2016-11-07 | 7,800 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | D To issuer deriv | 2016-11-04 | 2016-11-07 | 16,300 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | D To issuer deriv | 2016-11-04 | 2016-11-07 | 16,300 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | D To issuer | 2016-11-04 | 2016-11-07 | 11,567 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | G Gift | 2016-10-31 | 2016-11-07 | 3,350 | $52.90 | $177.2K | 11,567 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2016-06-17 | 2016-06-20 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award | 2016-06-17 | 2016-06-20 | 3,000 | — | $0 | 3,000 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2016-04-26 | 2016-04-28 | 16,300 | — | $0 | 16,300 | SEC↗ |
| CPHD CEPHEID | A Award | 2016-04-26 | 2016-04-28 | 1,800 | — | $0 | 14,917 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | D To issuer deriv | 2015-10-01 | 2015-10-02 | 18,000 | — | $0 | 0 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | D To issuer deriv | 2015-10-01 | 2015-10-02 | 11,591 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2015-06-16 | 2015-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | A Award deriv | 2015-06-02 | 2015-06-04 | 11,591 | — | $0 | 11,591 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-05-11 | 2015-05-12 | 520 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-05-11 | 2015-05-12 | 5,000 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise deriv | 2015-05-11 | 2015-05-12 | 5,000 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-05-11 | 2015-05-12 | 5,000 | $7.00 | $35.0K | 5,520 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | S Sale | 2015-05-11 | 2015-05-12 | 10,520 | $38.33 | $403.2K | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-05-11 | 2015-05-12 | 520 | $7.00 | $3.6K | 520 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | M Exercise | 2015-05-11 | 2015-05-12 | 5,000 | $7.00 | $35.0K | 10,520 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2015-04-28 | 2015-04-28 | 16,300 | — | $0 | 16,300 | SEC↗ |
| CPHD CEPHEID | A Award | 2015-04-28 | 2015-04-28 | 1,800 | — | $0 | 13,117 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2015-04-22 | 2015-04-23 | 1,800 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2015-04-22 | 2015-04-23 | 1,800 | — | $0 | 11,317 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2015-02-25 | 2015-02-26 | 9,375 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | S Sale | 2015-02-25 | 2015-02-26 | 9,375 | $57.76 | $541.5K | 9,517 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2015-02-25 | 2015-02-26 | 9,375 | $31.85 | $298.6K | 18,892 | SEC↗ |
| KYTH KYTHERA BIOPHARMACEUTICALS | A Award deriv | 2014-12-31 | 2015-01-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2014-11-07 | 2014-11-10 | 9,375 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | S Sale | 2014-11-07 | 2014-11-10 | 9,375 | $51.07 | $478.8K | 9,517 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2014-11-07 | 2014-11-10 | 9,375 | $20.47 | $191.9K | 18,892 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2014-10-20 | 2014-10-22 | 12,500 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | S Sale | 2014-10-20 | 2014-10-22 | 11,900 | $45.83 | $545.4K | 10,117 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2014-10-20 | 2014-10-22 | 12,500 | — | $0 | 22,017 | SEC↗ |
| CPHD CEPHEID | S Sale | 2014-10-20 | 2014-10-22 | 600 | $46.32 | $27.8K | 9,517 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2014-06-27 | 2014-07-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2014-04-30 | 2014-05-01 | 867 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2014-04-30 | 2014-05-01 | 867 | — | $0 | 9,517 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2014-04-22 | 2014-04-23 | 16,300 | — | $0 | 16,300 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2014-04-22 | 2014-04-23 | 1,800 | — | $0 | 1,800 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2013-11-08 | 2013-11-13 | 12,500 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2013-11-08 | 2013-11-13 | 12,500 | $9.26 | $115.8K | 21,150 | SEC↗ |
| CPHD CEPHEID | S Sale | 2013-11-08 | 2013-11-13 | 12,500 | $41.44 | $518.0K | 8,650 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | A Award deriv | 2013-06-05 | 2013-06-07 | 14,101 | — | $0 | 14,101 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion deriv | 2013-05-28 | 2013-05-30 | 2,826 | — | $0 | 0 | SEC↗ |
| PTLA PORTOLA PHARMACEUTICALS IN | C Conversion | 2013-05-28 | 2013-05-30 | 2,826 | — | $0 | 2,826 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2013-05-15 | 2013-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2013-04-30 | 2013-05-01 | 867 | — | $0 | 867 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2013-04-30 | 2013-05-01 | 7,800 | — | $0 | 7,800 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2013-04-24 | 2013-04-25 | 1,050 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2013-04-24 | 2013-04-25 | 1,050 | — | $0 | 8,650 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2012-06-13 | 2012-06-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2012-05-23 | 2012-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2012-04-26 | 2012-04-26 | 1,050 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2012-04-26 | 2012-04-26 | 1,050 | — | $0 | 7,600 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2012-04-24 | 2013-05-01 | 867 | — | $0 | 867 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2012-04-24 | 2013-05-01 | 7,800 | — | $0 | 7,800 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2012-04-24 | 2012-04-26 | 1,050 | — | $0 | 1,050 | SEC↗ |
| CPHD CEPHEID | A Award deriv | 2012-04-24 | 2012-04-26 | 9,375 | — | $0 | 9,375 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2012-02-06 | 2012-02-06 | 7,500 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | S Sale | 2012-02-06 | 2012-02-06 | 2,500 | $43.13 | $107.8K | 6,550 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2012-02-06 | 2012-02-06 | 7,500 | $8.65 | $64.9K | 9,050 | SEC↗ |
| CPHD CEPHEID | M Exercise deriv | 2012-02-03 | 2012-02-06 | 12,500 | — | $0 | 0 | SEC↗ |
| CPHD CEPHEID | M Exercise | 2012-02-03 | 2012-02-06 | 12,500 | $11.85 | $148.1K | 14,050 | SEC↗ |
| CPHD CEPHEID | S Sale | 2012-02-03 | 2012-02-06 | 12,500 | $43.20 | $540.0K | 1,550 | SEC↗ |